Bile Duct Cancer Research from Dana-Farber Cancer Institute

3 Views
administrator
administrator
06/16/23

New treatment options are greatly needed in Bile Duct Cancer (cholangiocarcinoma). New research led by Dana-Farber's James Cleary, MD, PhD in Cancer Discovery finds FGFR2 deletion may predict clinical benefit to molecularly targeted therapy. Video published April 30, 2021.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next